1. Home
  2. GOSS vs ORRF Comparison

GOSS vs ORRF Comparison

Compare GOSS & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

N/A

Current Price

$0.50

Market Cap

615.7M

Sector

Health Care

ML Signal

N/A

Logo Orrstown Financial Services Inc

ORRF

Orrstown Financial Services Inc

N/A

Current Price

$35.33

Market Cap

734.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GOSS
ORRF
Founded
2015
1919
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
615.7M
734.3M
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
GOSS
ORRF
Price
$0.50
$35.33
Analyst Decision
Buy
Buy
Analyst Count
9
1
Target Price
$4.91
$42.00
AVG Volume (30 Days)
27.3M
140.7K
Earning Date
01-01-0001
04-28-2026
Dividend Yield
N/A
3.41%
EPS Growth
78.81
N/A
EPS
N/A
3.07
Revenue
$114,701,000.00
$27,312,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.49
P/E Ratio
N/A
$11.46
Revenue Growth
N/A
40.21
52 Week Low
$0.33
$25.57
52 Week High
$3.87
$40.72

Technical Indicators

Market Signals
Indicator
GOSS
ORRF
Relative Strength Index (RSI) 23.06 40.01
Support Level $0.33 $34.51
Resistance Level $1.23 $35.28
Average True Range (ATR) 0.09 1.08
MACD -0.00 -0.25
Stochastic Oscillator 8.98 26.99

Price Performance

Historical Comparison
GOSS
ORRF

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.

Share on Social Networks: